Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+43.7%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
+43.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
20251267.79%
2024-5.44%
2023-19.84%
2022427.32%
2021-117.65%
20200.00%